Virtus Biotech Clinical Trials ETF (BBC) |
| 47.42 1.036 (2.23%) 04-17 15:59 |
| Open: | 47 |
| High: | 47.81 |
| Low: | 46.84 |
| Volume: | 28,055 |
| Market Cap: | 38(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 55.84 |
| Resistance 1: | 47.81 |
| Pivot price: | 43.46 |
| Support 1: | 42.14 |
| Support 2: | 38.63 |
| 52w High: | 47.81 |
| 52w Low: | 16.6 |
The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Sun, 19 Apr 2026
Liquidity Mapping Around (BBC) Price Events - Stock Traders Daily
Fri, 17 Apr 2026
Biotech ETF (BBC) touches fresh 52-week high - MSN
Fri, 10 Apr 2026
Biotech ETF (BBC) Touches Fresh 52-Week High - TradingView
Wed, 08 Apr 2026
Why (BBC) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Sat, 28 Mar 2026
Understanding Momentum Shifts in (BBC) - Stock Traders Daily
Thu, 08 Jan 2026
What's Going On With Alumis Stock Thursday? - Benzinga
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
